Leiv Lea
First SEC filing: March 22, 2016 · Latest: Feb. 10, 2017
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 4, 2025 | CRVS | A | 400,000 | · | · | 400,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 20, 2024 | CRVS | A | 300,000 | · | · | 300,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 6, 2023 | CRVS | A | 200,000 | · | · | 200,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 14, 2022 | CRVS | P | 4,000 | $0.84 | $3,360 | 133,238 Indirect | +3.10% | Acquired | 1197.6% (price as of 2026-10-02) |
| Dec. 13, 2022 | CRVS | P | 30,000 | $0.74 | $22,200 | 129,238 Indirect | +30.23% | Acquired | 1373.0% (price as of 2026-10-02) |
| Aug. 11, 2022 | CRVS | A | 160,000 | · | · | 160,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 17, 2022 | CRVS | P | 13,878 | $1.65 | $22,899 | 99,238 Indirect | +16.26% | Acquired | 560.6% (price as of 2026-10-02) |
| March 16, 2022 | CRVS | P | 35,160 | $1.54 | $54,146 | 85,360 Indirect | +70.04% | Acquired | 607.8% (price as of 2026-10-02) |
| Sept. 9, 2021 | CRVS | A | 160,000 | · | · | 160,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2020 | CRVS | A | 160,000 | · | · | 160,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 12, 2019 | CRVS | A | 160,000 | · | · | 160,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 7, 2019 | CRVS | P | 10,000 | $3.38 | $33,800 | 50,200 Indirect | +24.88% | Acquired | 222.5% (price as of 2026-10-02) |
| June 6, 2019 | CRVS | P | 15,500 | $3.56 | $55,180 | 40,200 Indirect | +62.75% | Acquired | 206.2% (price as of 2026-10-02) |
| Dec. 21, 2018 | CRVS | P | 24,700 | $4.15 | $102,505 | 24,700 Indirect | · | Acquired | 162.7% (price as of 2026-10-02) |
| Dec. 12, 2018 | CRVS | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 13, 2017 | CRVS | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 7, 2016 | CRVS | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 29, 2016 | CRVS | C | 42,608 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-02) |
| March 29, 2016 | CRVS | C | 42,608 | · | · | 199,253 Indirect | +27.20% | Acquired | (price as of 2026-10-02) |
| March 22, 2016 | CRVS | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 4, 2025 | CRVS | Stock Option (Right to Buy) | Common Stock | $8.81 | Dec. 4, 2035 | 400,000 | Acquired |
| Dec. 20, 2024 | CRVS | Stock Option (Right to Buy) | Common Stock | $4.99 | Dec. 20, 2034 | 300,000 | Acquired |
| Dec. 6, 2023 | CRVS | Stock Option (Right to Buy) | Common Stock | $1.64 | Dec. 6, 2033 | 200,000 | Acquired |
| Aug. 11, 2022 | CRVS | Stock Option (Right to Buy) | Common Stock | $0.96 | Aug. 11, 2032 | 160,000 | Acquired |
| Sept. 9, 2021 | CRVS | Stock Option (Right to Buy) | Common Stock | $2.60 | Sept. 9, 2031 | 160,000 | Acquired |
| Dec. 16, 2020 | CRVS | Stock Option (Right to Buy) | Common Stock | $4.01 | Dec. 16, 2030 | 160,000 | Acquired |
| Dec. 12, 2019 | CRVS | Stock Option (Right to Buy) | Common Stock | $3.54 | Dec. 12, 2029 | 160,000 | Acquired |
| Dec. 12, 2018 | CRVS | Stock Option (Right to Buy) | Common Stock | $5.94 | Dec. 12, 2028 | 100,000 | Acquired |
| Dec. 13, 2017 | CRVS | Stock Option (Right to Buy) | Common Stock | $10.60 | Dec. 13, 2027 | 40,000 | Acquired |
| Dec. 7, 2016 | CRVS | Stock Option (Right to Buy) | Common Stock | $16.37 | Dec. 7, 2026 | 25,000 | Acquired |
| March 29, 2016 | CRVS | Series A Preferred Stock | Common Stock | · | · | 42,608 | Disposed |
| March 22, 2016 | CRVS | Stock Option (Right to Buy) | Common Stock | $15.00 | March 22, 2026 | 60,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $291,437 | · | · | $303,605 | · | · | $2,000 | $597,042 |
| 2016 | $264,904 | · | · | $938,545 | · | · | · | $1,203,449 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.